Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Adverum Biotechnologies, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 59 | 55 | −4 |
| Shares | 57.3M | 62.7M | +5.42M (+9.5%) |
| Value | $33.2M | $45.0M | +$11.8M (+35.5%) |
New holders (5)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commodore Capital LP | 5,000,000 | $3.59M | 0.55% |
| Goldman Sachs Group Inc | 4,557,659 | $3.27M | 0.00% |
| Cubist Systematic Strategies, LLC | 31,506 | $22.6K | 0.00% |
| Group One Trading, L.P. | 21,574 | $15.5K | 0.00% |
| Ronald Blue Trust, Inc. | 1,500 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 465,000 | $269.5K |
| Marshall Wace, LLP | 341,397 | $198.0K |
| Invesco Ltd. | 304,246 | $176.3K |
| Acadian Asset Management LLC | 129,212 | $74.0K |
| Ergoteles LLC | 82,499 | $47.8K |
| Schonfeld Strategic Advisors LLC | 31,200 | $18.1K |
| Tudor Investment Corp Et Al | 12,131 | $7.00K |
| Merit Financial Group, LLC | 10,000 | $5.79K |
| IFP Advisors, Inc | 6,000 | – |